SCHEMBL18879050

SCHEMBL18879050

Nc1cnnc2[nH]nnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17546642 0.74 CYP1A2 (0.32)
SCHEMBL18879052 0.71 CYP1A2 (0.30)
SCHEMBL17545819 0.69
SCHEMBL18879003 0.68 PARP1 (0.34)
SCHEMBL7586931 0.67 CHEK1 (0.30)
SCHEMBL24639 0.62 PI4KA (0.42)
SCHEMBL12692616 0.61
SCHEMBL17595861 0.61 ALDH1A1 (0.31)
SCHEMBL15598533 0.58 YTHDC1 (0.33)
SCHEMBL922887 0.58 GAA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145009-A1 HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEFUL FOR TREATING VARIOUS CANCERS EFFECTOR THERAPEUTICS, INC. 2017-05-25 US disclosed